An RF and semiconductor engineer explains why AI can’t compensate for hardware and connectivity errors, and what questions to ask instead.
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
- The Cost And ROI Of Agentic AI In Clinical Trials: What Sponsors And CROs Need To Know
- Designing eCOA Technology Patients Can Actually Use
- Clinical Trial Technology Doesn't Fail – It Fails At The Handoff
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Remote Captured Sleep Data Unlocks New Clinical Insights
Gathering rich, real-world data in formal clinical trials has been difficult. Gain insight into ways to start collecting quality sleep data remotely by leveraging cloud-based data ingestion and processing.
-
How To Improve Patient Engagement In Clinical Trials
Stronger patient engagement improves recruitment, retention, and data quality. Reducing burden, improving communication, and meeting real needs can transform trials and keep studies on track.
-
Televisits: Why Integrate Telemedecine Features In eCOA Trials?
Discover new possibilities where patients can complete several of their clinical study procedures remotely, making their participation in clinical trials easier and less cumbersome than site-based trials.
-
Hope In The Dark: Value In Alzheimer's Disease Research And Treatment
The May/June 2025 issue of Value & Outcomes Spotlight explores the health economics and outcomes research (HEOR) and its contribution to research and treatment of Alzheimer’s disease.
-
Transforming Field Rep Success
As the healthcare landscape evolves, maintaining accurate and timely information delivery becomes vital for building strong HCP relationships and improving patient outcomes.
-
Embracing Accessibility: The Future Of Clinical Trials
Explore the reasons why accessibility stands as a crucial pillar for the prosperity of biopharmaceutical and clinical research, having evolved into an all-encompassing industry imperative.
-
The Case For Cognitive Assessments In Phase 1 Clinical Trials
Regulators prioritize patient-reported outcomes. Cognitive assessments in Phase 1 trials detect early drug-related cognitive effects, ensuring safety and efficacy. Signant’s CDR System® is a proven tool for this.
-
The Power Of Predictive Analytics In Clinical Trial Design
Discover how predictive analytics address clinical trial challenges by applying statistical and modeling techniques to current and historical data.
-
eClinical Platform Accelerates COVID-19 Treatment Trial By 2 Weeks
Examine a COVID-19 treatment trial that utilized integrated EDC, eConsent, eCOA, RTSM, and TeleVisit solutions, all within a single platform, to address three critical challenges.
-
Expand Clinical Trial Recruitment With Advanced Analytics And AI
Using advanced analytics and AI can help clinical trial leaders identify and enroll a broader, more diverse patient population, accelerating research.
- What AI Can't Fix In Decentralized Clinical Trial Data
- Decentralized Trials Promised Less Burden. Did They Deliver?
- Wireless Connectivity Is A Data Integrity Issue, Not IT
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
RECENT NEWSLETTERS
- 08.13.26 -- AI Urgency, Site-Sponsor Gaps, And Data That Saves Lives
- 08.06.26 -- Clinical Trial Tech: AI, Data Quality, And Faster Study Build
- 08.01.26 -- July's Top Clinical Trial Tech Reads
- 07.30.26 -- Clinical Tech Leadership: Site Burden, AI ROI, And Smarter Trial Tech
- 07.23.26 -- AI, Data Costs, And The Real Barriers To Trial Execution